Florencia Griffin, PA
Physician Assistant · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 11 years
- Graduated 2015
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Hospitals listed: Marinhealth Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Florencia Griffin’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
State licence records
1 licence
- Texas PA11893Physician Assistant License · since 2018 · expires 2023-08-31Cancelled Non-RenewalNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$25,756
Medicare paid this office $25,756 for 114 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Transitional care management services for problem of high complexity | 42 | $9,979 | $238 |
| Return visit (30+ min) | 53 | $7,588 | $107 |
| Short return visit (20+ min) | 37 | $3,583 | $76 |
Who their Medicare patients are
114 Original Medicare patients in 2024. Average age 81 · Under 65 0% · 85 and older 35% · Women 39% · Health risk score 1.48. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Coronary heart disease 74% · Atrial fibrillation 55% · Heart failure 54% · Chronic kidney disease 45% · Diabetes 27% · Cancer 22% · Depression 21% · Stroke 17% · COPD 14% · Dementia 10%.
The office billed $134,656, Medicare allowed $32,159 and paid $25,756; for 200 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 114 | 200 | 81 | 1.48 | $134,656 | $25,756 |
| 2021 | 17 | 20 | 72 | 1.16 | $4,930 | $1,506 |
| 2019 | 22 | 47 | 72 | 1.50 | $8,373 | $2,072 |
| 2018 | 18 | 30 | 73 | 1.99 | $7,010 | $1,808 |
| 2017 | 14 | 18 | 73 | 1.80 | $9,050 | $810 |
| 2016 | 11 | 16 | 69 | 1.40 | $9,514 | $891 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2019: 2 services
| Return visit (30+ min) | 15 | $1,379 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 11 | $152 | $11 |
2017: 1 service
| Short return visit (20+ min) | 13 | $726 | $43 |
Drugs they prescribed that Part D paid
$34,991
Pharmacies billed $34,991 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 344) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
304 generic and 40 brand-name prescriptions · $34,991 in drug cost · 71 antibiotic prescriptions to 66 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 14 | $15,904 | $1,136 |
| Brilinta | 11 | $5,724 | $520 |
| Metoprolol | 34 | $381 | $11 |
| Lisinopril | 22 | $280 | $13 |
| Amlodipine Besylate | 30 | $249 | $8 |
See all 10 drugs
| Eliquis | 14 | $15,904 | $1,136 |
| Brilinta | 11 | $5,724 | $520 |
| Metoprolol | 34 | $381 | $11 |
| Lisinopril | 22 | $280 | $13 |
| Amlodipine Besylate | 30 | $249 | $8 |
| Clopidogrel | 20 | $246 | $12 |
| Furosemide | 22 | $165 | $8 |
| Amoxicillin | 61 | $130 | $2 |
| Atorvastatin | 22 | $125 | $6 |
| Carvedilol | 12 | $103 | $9 |
Year by year
| 2024 | 344 | 146 | 0% (0) | 12% | $34,991 |
| 2023 | 93 | 26 | 0% (0) | 19% | $17,905 |
| 2022 | 437 | 53 | 0% (0) | None | $42,049 |
| 2021 | 433 | 55 | 0% (0) | 13% | $38,899 |
| 2020 | 396 | 51 | 0% (0) | 13% | $24,073 |
| 2019 | 328 | 70 | 0% (0) | 15% | $22,073 |
| 2018 | 395 | 101 | 0% (0) | 11% | $23,147 |
| 2017 | 256 | 78 | 0% (0) | 13% | $10,684 |
| 2016 | 12 | None | 0% (0) | 0% | $194 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Metoprolol | 12 | $112 | $9 |
2022: 13 drugs
| Eliquis | 18 | $13,512 | $751 |
| Entresto | 11 | $12,639 | $1,149 |
| Multaq | 12 | $9,256 | $771 |
| Metoprolol | 59 | $1,205 | $20 |
| Ezetimibe | 21 | $509 | $24 |
| Atorvastatin | 40 | $473 | $12 |
| Losartan | 36 | $369 | $10 |
| Isosorbide Mononitrate Er | 15 | $345 | $23 |
| Hydralazine | 11 | $304 | $28 |
| Rosuvastatin | 28 | $239 | $9 |
| Amlodipine Besylate | 36 | $120 | $3 |
| Furosemide | 17 | $98 | $6 |
| Lisinopril | 23 | $96 | $4 |
2021: 12 drugs
| Eliquis | 19 | $11,841 | $623 |
| Entresto | 11 | $10,511 | $956 |
| Metoprolol | 76 | $1,359 | $18 |
| Atorvastatin | 37 | $517 | $14 |
| Ezetimibe | 14 | $409 | $29 |
| Losartan | 26 | $294 | $11 |
| Isosorbide Mononitrate Er | 21 | $282 | $13 |
| Lisinopril | 27 | $270 | $10 |
| Rosuvastatin | 18 | $190 | $11 |
| Amlodipine Besylate | 31 | $163 | $5 |
| Pantoprazole | 12 | $156 | $13 |
| Metoprolol | 20 | $111 | $6 |
2020: 13 drugs
| Metoprolol | 53 | $1,680 | $32 |
| Ezetimibe | 18 | $882 | $49 |
| Atorvastatin | 50 | $646 | $13 |
| Hydralazine | 18 | $585 | $32 |
| Rosuvastatin | 15 | $500 | $33 |
| Labetalol | 11 | $478 | $43 |
| Amlodipine Besylate | 39 | $402 | $10 |
| Carvedilol | 20 | $185 | $9 |
| Pantoprazole | 12 | $172 | $14 |
| Losartan | 22 | $141 | $6 |
| Furosemide | 19 | $118 | $6 |
| Lisinopril | 15 | $114 | $8 |
| Metoprolol | 12 | $42 | $3 |
2019: 9 drugs
| Metoprolol | 52 | $1,479 | $28 |
| Rosuvastatin | 25 | $510 | $20 |
| Atorvastatin | 26 | $374 | $14 |
| Hydralazine | 21 | $334 | $16 |
| Carvedilol | 13 | $119 | $9 |
| Lisinopril | 19 | $113 | $6 |
| Furosemide | 16 | $108 | $7 |
| Amlodipine Besylate | 15 | $77 | $5 |
| Losartan | 13 | $49 | $4 |
2018: 10 drugs
| Metoprolol | 38 | $1,016 | $27 |
| Atorvastatin | 38 | $650 | $17 |
| Chlorthalidone | 16 | $629 | $39 |
| Rosuvastatin | 15 | $556 | $37 |
| Amlodipine Besylate | 24 | $357 | $15 |
| Nifedipine Er | 12 | $186 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $160 | $15 |
| Losartan | 20 | $126 | $6 |
| Furosemide | 15 | $98 | $7 |
| Lisinopril | 26 | $59 | $2 |
2017: 6 drugs
| Metoprolol | 25 | $635 | $25 |
| Atorvastatin | 20 | $373 | $19 |
| Carvedilol | 13 | $73 | $6 |
| Amlodipine Besylate | 12 | $62 | $5 |
| Pantoprazole | 13 | $46 | $4 |
| Lisinopril | 15 | $37 | $2 |
Money from drug and device companies
$1,329 in 2025
| 2025 | 3 | 21 | None | $1,329 |
| 2024 | 4 | 22 | None | $1,455 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Edwards Lifesciences | Sapien 3 Ultra Resilia | $1,196 | 17 payments
|
| Boston Scientific | Watchman Flx | $116 | 3 payments
|
| B. Braun Interventional Systems | Cp Stent | $17 | 1 payment
|
See all 21 published payments
| B. Braun Interventional Systems | Meals · 2025-11-06 | Cp Stent | $17 |
| Boston Scientific | Meals · 2025-07-02 | Watchman Flx | $36 |
| Edwards Lifesciences | Travel · 2025-06-20 | Sapien 3 Ultra Resilia | $24 |
| Edwards Lifesciences | Travel · 2025-06-20 | Sapien 3 Ultra Resilia | $82 |
| Edwards Lifesciences | Travel · 2025-06-20 | Sapien 3 Ultra Resilia | $318 |
| Edwards Lifesciences | Meals · 2025-06-19 | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $34 |
| Edwards Lifesciences | Meals · 2025-06-19 | Sapien 3 Ultra Resilia | $20 |
| Edwards Lifesciences | Meals · 2025-06-19 | Sapien 3 Ultra Resilia | $120 |
| Edwards Lifesciences | Meals · 2025-06-19 | Sapien 3 Ultra Resilia | $23 |
| Edwards Lifesciences | Meals · 2025-06-19 | Sapien 3 Ultra Resilia | $7 |
| Edwards Lifesciences | Meals · 2025-06-19 | Sapien 3 Ultra Resilia | $47 |
| Edwards Lifesciences | Meals · 2025-06-19 | Sapien 3 Ultra Resilia | $14 |
| Edwards Lifesciences | Travel · 2025-06-19 | Sapien 3 Ultra Resilia | $86 |
| Edwards Lifesciences | Travel · 2025-06-19 | Sapien 3 Ultra Resilia | $25 |
| Edwards Lifesciences | Travel · 2025-06-19 | Sapien 3 Ultra Resilia | $35 |
| Edwards Lifesciences | Education · 2025-06-19 | Sapien 3 Ultra Resilia | $1 |
| Edwards Lifesciences | Meals · 2025-06-13 | Sapien 3 Ultra Resilia | $35 |
| Edwards Lifesciences | Meals · 2025-05-30 | None | $29 |
| Edwards Lifesciences | Travel · 2025-05-09 | None | $295 |
| Boston Scientific | Meals · 2025-02-18 | Watchman Flx | $34 |
| Boston Scientific | Meals · 2025-01-28 | Watchman Flx | $46 |
See earlier years (2024)
2024: $1,455
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve (Thv) | $1,032 | 13 payments
|
| Heartflow | Ffrct | $263 | 3 payments
|
| Boston Scientific | Watchman Flx | $137 | 5 payments
|
| Abbott Laboratories | Mitraclip | $24 | 1 payment
|
Professional record
- NPI
- 1235594425
- Licence
- TX PA11893Texas PA11893: Cancelled Non-Renewal
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2015-12-15
- NPI last updated
- 2026-08-04
- NPI record certified
- 2026-08-04
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.